Nelfinavir (Viracept®) is an antiretroviral drug used in the treatment of the human immunodeficiency virus (HIV). Nelfinavir belongs to the class of drugs known as protease inhibitors (PIs) and like other PIs is generally used in combination with other antiretroviral drugs. Nelfinavir is presented as the mesilate (mesylate) ester prodrug.
The Food and Drug Administration approved it for therapeutic use on March 14, 1997, making it the twelfth approved antiretroviral. It never secured a large market share and newer PIs are generally preferred for first-line therapy.
More on [ Nelfinavir ]

DrugDigest: Nelfinavir ( Viracept ) - Information on dosage, usage, side effects, interactions, and drug comparisons, including generics when available.
Nelfinavir - a.k.a. Nelfinavir Mesylate, Viracept.
Nelfinavir - (Viracept)
Viracept - A potent protease inhibitor for treatment of HIV. (Nelfinavir Mesylate)
Meta Description: [ VIRACEPT is a protease inhibitor which when used in combination with other HIV medications offers effective treatment for HIV infection. ]
| Caution on Viracept in Children and Pregnant Women (Dec. 07) | |
| Next Video | |